Hospital Based Continuous Patient Monitoring System
Launched by UNIVERSITY OF ALABAMA AT BIRMINGHAM · Dec 16, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new way to monitor patients' vital signs, like heart rate and breathing, in hospitals in Ghana. Currently, many hospitals rely on manual monitoring, which can miss important changes in a patient’s condition. The researchers are testing a dashboard that uses a Fitbit, a popular wrist device, to continuously track these vital signs instead of traditional bedside monitors. This study aims to ensure that patients, especially children who have experienced trauma or undergone surgery for appendicitis, receive better care.
To be eligible for this trial, children between the ages of about 3 to 18 who have had a traumatic injury or surgery for appendicitis can participate. However, children who cannot wear a Fitbit due to missing upper limbs or allergies to rubber will not be included. If your child participates, they will wear the Fitbit to help the medical team monitor their health closely and make sure they are recovering well. This study is not yet recruiting participants, but it represents an exciting step toward improving patient monitoring in resource-limited settings.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Pediatric patients presenting with traumatic injury
- • Pediatric patients postoperative status after an appendectomy
- Exclusion Criteria:
- • Pediatric patients missing their upper limbs,
- • Pediatric patients who cannot wear a Fitbit on their wrist for known allergies to rubber or those with traumatic or medical conditions that prevent them from being able to comfortably wear a Fitbit on either hand
About University Of Alabama At Birmingham
The University of Alabama at Birmingham (UAB) is a prominent academic institution and research hub dedicated to advancing healthcare through innovative clinical trials. Renowned for its commitment to medical discovery and education, UAB conducts cutting-edge research across a wide array of disciplines, including oncology, cardiology, neurology, and public health. With a robust infrastructure for clinical research, UAB fosters collaboration among interdisciplinary teams, leveraging state-of-the-art facilities and resources to enhance the translation of scientific findings into effective treatments and interventions. As a leader in clinical research, UAB aims to improve patient outcomes and contribute to the broader medical community through rigorous trial design and implementation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported